Conversations in Lung Cancer Research

By Thoracic Oncology Group Of Australasia (TOGA)

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.


Category: Medicine

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast

Subscribers: 2
Reviews: 0
Episodes: 75

Description

Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.

Episode Date
The Evolving Landscape of ROS1-positive NSCLC
Sep 03, 2026
Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment
Aug 27, 2026
Smoking Stigma and Lung Cancer Care in the Screening Era
Aug 13, 2026
Dr. Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery
Jul 30, 2026
Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
Jun 25, 2026
Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
Jun 18, 2026
The Evolving Landscape of BRAF-Mutated NSCLC in Australia
Jun 04, 2026
Thymic Cancer: The Lesser-Known Thoracic Tumours
May 21, 2026
A/Prof Surein Arulananda: A Masterclass in Career Growth
May 07, 2026
TOGA ASM 2026: Program Review
Apr 16, 2026
ALK TKI Sequencing in the Australian Landscape
Apr 09, 2026
Professor Michael Millward: Clinical Insights in Lung Cancer Research
Feb 26, 2026
Dr. Megan Sanders: From Science to TOGA Leadership
Feb 12, 2026
Lung Cancer Research: 2025 Year in Review
Jan 29, 2026
New and Emerging Practice Standards in ES-SCLC
Dec 11, 2025
Exploring Lung Cancer Care and Research in New Zealand
Nov 27, 2025
Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
Oct 02, 2025
Prof. Anna Nowak: A Journey from Oncology Lab to Leadership
Sep 18, 2025
CNS Progression in Lung Cancer: A Practical Conversation on Best Practices
Sep 04, 2025
A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
Aug 14, 2025
Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
Jul 10, 2025
The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
Jun 19, 2025
Lessons from Fellowships and building Clinical Trials Units
Jun 05, 2025
Prof Wendy Cooper: Journey of a Thoracic Pathologist
May 21, 2025
Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
May 08, 2025
The Role of Liquid Biopsy in Modern Oncology
Mar 20, 2025
Exploring EGFR Exon 20 Insertion Mutations
Mar 06, 2025
From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
Feb 05, 2025
Introducing Conversations in Lung Cancer Research - Trailer
Feb 04, 2025
Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
Dec 12, 2024
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
Dec 02, 2024
Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
Nov 14, 2024
Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Sep 30, 2024
NTRK1, 2,3 And Other Rare Mutations In NSCLC
Aug 30, 2024
Decoding Perioperative Immunotherapy In NSCLC
Jul 25, 2024
Access to New Medicines: Which Surrogate Endpoints Matter
Jun 19, 2024
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
Apr 22, 2024
Underutilisation of Radiotherapy in Lung Cancer Treatment
Mar 27, 2024
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
Feb 28, 2024
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
Dec 15, 2023
Lung cancer Screening and Moving from Concept to Roll Out
Oct 31, 2023
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
Oct 06, 2023
Nature and nurture: lung cancer risk and implications for future screening
Aug 10, 2023
Operability in Stage III NSCLC
Jul 04, 2023
NSCLC and KRAS Mutations
Jun 06, 2023
Treatment Considerations in ALK-Positive NSCLC
Apr 21, 2023
Celebrating Female Leadership in Medical Research
Mar 08, 2023
Brain metastases in NSCLC
Feb 23, 2023
NGS panels in lung cancer
Dec 20, 2022
Lung Cancer Screening and its impact on patient care in Australia
Dec 07, 2022
The Management of Stage III NSCLC
Oct 31, 2022
The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
Oct 12, 2022
Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
Sep 01, 2022
Accelerating Progress in Oncogene-driven Lung Cancer
Aug 09, 2022
Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
Jul 24, 2022
Practical smoking cessation advice for health care providers
May 30, 2022
Consider Every Trial as a TeleTrial
Apr 30, 2022
EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
Mar 29, 2022
The need for a National Clinical Quality Registry in Lung Cancer
Feb 22, 2022
ALK treatment considerations in NSCLC
Dec 08, 2021
Stigma and Nihilism In Lung Cancer : A Call to Action
Nov 23, 2021
Challenging the Lung Cancer Stigma
Nov 08, 2021
The Value of Comprehensive Genomic Profiling in Lung Cancer
Oct 17, 2021
Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
Sep 24, 2021
Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
Jul 30, 2021
Long Term Survivorship: Thriving with Metastatic Lung Cancer
Jun 24, 2021
Women and Lung Cancer: The Rising Tide
May 14, 2021
Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer
Apr 01, 2021
Lung cancer screening works!
Mar 01, 2021
Dreaming of Better Treatments for Mesothelioma
Feb 16, 2021
Lung Cancer Careers: Preceptorship Reflections
Dec 13, 2020
Cancer won't wait: A Cancer Australia Perspective
Nov 25, 2020
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
Nov 18, 2020
Redefining Survival In Lung Cancer: Meet Alexandra
Nov 10, 2020
Improving Survival In Oncogene Driven Lung Cancer
Nov 10, 2020